NCT01965808View on ClinicalTrials.gov

A Study of LY2157299 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

LY2157299

Administered orally

Trial Locations (1)

31227

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01965808 - A Study of LY2157299 in Healthy Participants | Biotech Hunter | Biotech Hunter